🔎 Trials Near Me

Home › NCT07471685

Family Building Decision Support for Female Adolescent and Young Adult Cancer Survivors

Recruiting

Development and Pilot Testing of a Family Building Decision Support Intervention for Female Adolescent and Young Adult Cancer Survivors

Who can join

Ages 18 to 39 · Women

Full eligibility criteria
Inclusion Criteria:

* Female (biological sex) AYA cancer survivor age 15-39 at original diagnosis and 18-39 at enrollment.
* Completed cancer treatment with curative intent.
* Prior exposure to treatments posing gonadotoxic risk (e.g., alkylating agents, total body irradiation) and/or treatments increasing obstetric risk (e.g., chest radiation, radiation to uterus, anthracycline exposure).
* Has not completed family building.
* Able to speak/read English.
* Willing and able to complete videoconference sessions and REDCap surveys.

Exclusion Criteria:

* Visual, hearing, or cognitive impairment or severe mental illness that would interfere with participation as determined by study staff.

About the study

This study aims to develop and pilot-test a nurse navigator-delivered behavioral program to support female adolescent and young adult (AYA) cancer survivors in making informed, values-driven family-building decisions after completion of cancer treatment. Female AYA survivors often face fertility impairments, uncertainty about reproductive potential, elevated obstetric risks during pregnancy, and significant emotional distress related to parenthood planning. Currently, few interventions address these post-treatment decision-making needs.

The intervention consists of four videoconference sessions that combine personalized, risk-based reproductive health education with coping strategies derived from Acceptance and Commitment Therapy and Patient Activation Theory. A pilot randomized controlled trial will evaluate feasibility, acceptability, and preliminary changes in knowledge, decisional conflict, self-efficacy, and reproductive-health-related distress among 48 participants randomized to the intervention or a survivorship-education control condition. Findings will inform future testing of the intervention's efficacy in a larger clinical trial.

What is being tested

Sponsor: Duke University · Participants: 48 · Started: May 11, 2026

Contact the study team

Official record on ClinicalTrials.gov — NCT07471685

Locations in the U.S.

North CarolinaDuke Cancer Institute, Durham

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.